Advanced Pharmaceutical Technology, Inc. recalls TESTO-200
- Published
- 2 Jul 2025
- Units affected
- 26 vials
- Agency
- FDA
- Country
- United States
The hazard
Marketed Without an Approved NDA/ANDA
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01
- Brand / company
- Advanced Pharmaceutical Technology, Inc.
- Codes / lots
- Lot P-24-1; Exp. 02/28/2027
- Distribution
- NY, NJ
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 2 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.